FOXP2 and diffuse large B-cell lymphoma: Due to our interest in FOXP1 as a future therapeutic target in DLBCL we also aimed to determine whether FOXP2 might function independently of FOXP1 or whether these transcriptional factors might be co-expressed and exhibit potential functional cooperativity.